ABX-196 Uses, Dosage, Side Effects and more
ABX-196 is under investigation in clinical trial NCT03897543 (ABX196 in Combination With Nivolumab in Patients With Hepatocellular Carcinoma).
Trade Name | ABX-196 |
Generic | ABX-196 |
Type | |
Formula | C50H98N2O9 |
Weight | Average: 871.339 Monoisotopic: 870.727232744 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |